While the biological function of the NIPBL-ERG fusion at present is not known, given the lack of mechanistic studies, our findings suggest that the fusion exerts its function in an analogous manner to TMPRSS2-ERG in prostate cancer. The gene discussed is TMPRSS2; the disease is prostate carcinoma.